Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth. Nep. Med. J. 2020;3(1):309-312. doi:10.3126/nmj.v3i1.28726